Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = breast cancer
  • (-) ≠ endocrine therapy
  • (-) ≠ Groot, S. de

Refine Results

Resource Type

Availability

Creation Date

Show more

Faculty

Collection

Topic

Show more

Author

Show more

Language

Search results

  • RSS Feed
(61 - 80 of 108)

Pages

Morphological and phenotypical features of ovarian metastases in breast cancer patients
Peters, I.T.A.; Steen, M.A. van der; Huisman, B.W.; Hilders, C.G.J.M.; Smit, V.T.H.B.M.; Vahrmeijer, A.L.; ... ; Kuppen, P.J.K. 2017
Morphological and phenotypical features of ovarian metastases in breast cancer patients
Article / Letter to editor
metadata only
Combined evaluation of the FAS cell surface death receptor and CD8+tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer
Blok, E.J.; Bulk, J. van den; Dekker-Ensink, N.G.; Derr, R.; Kanters, C.; Bastiaannet, E.; ... ; Kuppen, P.J.K. 2017
Combined evaluation of the FAS cell surface death receptor and CD8+tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer
Article / Letter to editor
metadata only
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21
Hamdi, Y.; Soucy, P.; Adoue, V.; Michailidou, K.; Canisius, S.; Lemacon, A.; ... ; KConFab AOCS Investigators 2016
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21
Article / Letter to editor
metadata only
Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients
Lam, S.W.; Frederiks, C.N.; Straaten, T. van der; Honkoop, A.H.; Guchelaar, H.J.; E. boven 2016
Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients
Article / Letter to editor
metadata only
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
Zaaijer, L.H.; Doorn, H.C. van; Mourits, M.J.E.; Beurden, M. van; Hullu, J.A. de; Adank, M.A.; ... ; Kriege, M. 2016
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
Article / Letter to editor
metadata only
Functional Analysis of Missense Variants in the Putative Breast Cancer Susceptibility Gene XRCC2
Hilbers, F.S.; Luijsterburg, M.S.; Wiegant, W.W.; Meijers, C.M.; Volker-Albert, M.; Boonen, R.A.; ... ; Attikum, H. van 2016
Functional Analysis of Missense Variants in the Putative Breast Cancer Susceptibility Gene XRCC2
Article / Letter to editor
metadata only
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Shi, J.J.; Zhang, Y.F.; Zheng, W.; Michailidou, K.; Ghoussaini, M.; Bolla, M.K.; ... ; Long, J.R. 2016
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Article / Letter to editor
metadata only
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17
Tummers, Q.R.J.G.; Hoogstins, C.E.S.; Gaarenstroom, K.N.; Kroon, C.D. de; Poelgeest, M.I.E. van; Vuyk, J.; ... ; Vahrmeijer, A.L. 2016
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17
Article / Letter to editor
metadata only
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17
Tummers, Q.R.J.G.; Hoogstins, C.E.S.; Gaarenstroom, K.N.; Kroon, C.D. de; Poelgeest, M.I.E. van; Vuyk, J.; ... ; Vahrmeijer, A.L. 2016
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17
Article / Letter to editor
metadata only
Conclusions: FR alpha is a favorable target for fluorescence-guided surgery as EC17 produced a clear fluorescent signal in ovarian and breast cancer tissue. This resulted in resection of ovarian... Show moreConclusions: FR alpha is a favorable target for fluorescence-guided surgery as EC17 produced a clear fluorescent signal in ovarian and breast cancer tissue. This resulted in resection of ovarian cancer lesions that were otherwise not detected. Notwithstanding, autofluorescence caused false-positive lesions in ovarian cancer and difficulty in discriminating breast cancer-specific fluorescence from background signal. Optimization of the 500nm fluorophore, will minimize autofluorescence and further improve intraoperative tumor detection. Show less
Validity of the online PREDICT tool in older patients with breast cancer: a population-based study
Glas, N.A. de; Bastiaannet, E.; Engels, C.C.; Craen, A.J.M. de; Putter, H.; Velde, C.J.H. van de; ... ; Portielje, J.E.A. 2016
Validity of the online PREDICT tool in older patients with breast cancer: a population-based study
Article / Letter to editor
metadata only
SNP-SNP interaction analysis of NF-kappa B signaling pathway on breast cancer survival
Jamshidi, M.; Fagerholm, R.; Khan, S.; Aittomaki, K.; Czene, K.; Darabi, H.; ... ; kConFab Investigators 2015
SNP-SNP interaction analysis of NF-kappa B signaling pathway on breast cancer survival
Article / Letter to editor
metadata only
Prognostic and predictive value of ER beta 1 and ER beta 2 in the Intergroup Exemestane Study (IES)-first results from PathIES(aEuro)
Speirs, V.; Viale, G.; Mousa, K.; Palmieri, C.; Reed, S.N.; Nicholas, H.; ... ; PathIES Sub-Comm 2015
Prognostic and predictive value of ER beta 1 and ER beta 2 in the Intergroup Exemestane Study (IES)-first results from PathIES(aEuro)
Article / Letter to editor
metadata only
Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
Henneman, L.; Miltenburg, M.H. van; Michalak, E.M.; Braumuller, T.M.; Jaspers, J.E.; Drenth, A.P.; ... ; Jonkers, J. 2015
Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
Article / Letter to editor
metadata only
Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial
Fontein, D.B.Y.; Grand, M.K.; Nortier, J.W.R.; Seynaeve, C.; Kranenbarg, E.M.K.; Dirix, L.Y.; ... ; Putter, H. 2015
Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial
Article / Letter to editor
metadata only
Stick Together: A Nordic Walking Group Intervention for Breast Cancer Survivors
Fischer, M.J.; Krol-Warmerdam, E.M.M.; Ranke, G.M.C.; Vermeulen, H.M.; Heijden, J. van der; Nortier, J.W.R.; Kaptein, A.A. 2015
Stick Together: A Nordic Walking Group Intervention for Breast Cancer Survivors
Article / Letter to editor
metadata only
Total dietary antioxidant capacity, individual antioxidant intake and breast cancer risk: The Rotterdam study
Pantavos, A.; Ruiter, R.; Feskens, E.F.; Keyser, C.E. de; Hofman, A.; Stricker, B.H.; ... ; Kiefte-de Jong, J.C. 2015
Total dietary antioxidant capacity, individual antioxidant intake and breast cancer risk: The Rotterdam study
Article / Letter to editor
metadata only
Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGF beta receptor I kinase
Buijs, J.T.; Matula, K.M.; Cheung, H.; Kruithof-de Julio, M.; Mark, M.H. van der; Snoeks, T.J.; ... ; Pluijm, G. van der 2015
Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGF beta receptor I kinase
Article / Letter to editor
metadata only
Healthcare utilisation in patients with breast cancer or non-Hodgkin lymphoma who experienced febrile neutropenia in the Netherlands: a retrospective matched control study using the PHARMO database
Issa, D.E.; Gelderblom, H.; Lugtenburg, P.J.; Herk-Sukel, M.P. van; Houweling, L.M.A.; Orden, M. de la; ... ; Jong, F.A. de 2015
Healthcare utilisation in patients with breast cancer or non-Hodgkin lymphoma who experienced febrile neutropenia in the Netherlands: a retrospective matched control study using the PHARMO database
Article / Letter to editor
metadata only
Improved overall survival after contralateral risk-reducing mastectomy in brca1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis
Heemskerk-Gerritsen, B.A.M.; Rookus, M.A.; Aalfs, C.M.; Ausems, M.G.E.M.; Collee, J.M.; Jansen, L.; ... ; HEBON 2015
Improved overall survival after contralateral risk-reducing mastectomy in brca1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis
Article / Letter to editor
metadata only
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: A national cohort study
Saadatmand, S.; Vos, J.R.; Hooning, M.J.; Oosterwijk, J.C.; Koppert, L.B.; Bock, G.H. de; ... ; Hereditary Breast Ovarian Canc Res 2014
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: A national cohort study
Article / Letter to editor
metadata only

Pages